Your body needs more than willpower.
GLP-1 injectable medications work with your biology — reducing hunger at the hormonal level, slowing digestion, and making your body's fat-burning mechanisms work again. Medically supervised. Weekly injection. Real results.
This isn't a motivation problem. It's a biology problem.
Most people who struggle with weight loss aren't doing anything wrong — their body's hunger and metabolism signals are working against them. That's not a personal failure. It's physiology. And physiology can be treated.
You eat a meal and feel satisfied for an hour. Then hunger creeps back — not because you lack discipline, but because GLP-1 hormone signaling is dysregulated. Injectable GLP-1 medications correct this at the source.
You've lost weight before — maybe multiple times. But it always returns. This is a known biological phenomenon called 'weight regain' driven by adaptive metabolic changes that diet alone can't overcome.
You're eating less, moving more, and the scale hasn't moved in weeks. Metabolic adaptation — your body lowering its baseline energy expenditure — is a real, documented obstacle that medication helps bypass.
Elevated fasting glucose, insulin resistance, or pre-diabetes are often part of the same metabolic picture as excess weight. Semaglutide and Tirzepatide address both simultaneously.
Carrying excess weight is physically taxing — on joints, on the cardiovascular system, on sleep quality. As weight comes off with medical support, energy typically improves significantly within the first 4–8 weeks.
Years of trying — and feeling like you're the problem — takes a psychological toll. Medical weight loss removes the moral framework from the equation and replaces it with a clinical one. The weight is a condition. The medication treats the condition.
If any of these sound familiar, your biology may be working against you.
A comprehensive metabolic evaluation at IUVENTUS identifies the specific factors driving your weight gain — and determines which injectable program will produce the best results for your body.
Your body is designed to hold onto weight.
When you restrict calories, your body responds by lowering its metabolic rate, increasing hunger hormones, and prioritizing fat storage — a survival mechanism that evolved over thousands of years. This is why virtually all diet-only approaches fail long-term. You're not fighting bad habits; you're fighting evolutionary biology.
GLP-1 (glucagon-like peptide-1) is a hormone released in the gut after eating that signals fullness to the brain. In many people, this signaling is blunted or insufficient — leading to chronic overconsumption without a subjective sense of excess. GLP-1 receptor agonists like Semaglutide and Tirzepatide replicate and amplify this signal, creating a genuine sense of satiety that caloric restriction alone cannot reproduce.
Tirzepatide adds a second mechanism — GIP (glucose-dependent insulinotropic polypeptide) receptor agonism — that enhances insulin sensitivity and energy metabolism. The dual-action mechanism is why Tirzepatide clinical trials show results approaching surgical weight loss outcomes in some patient groups.
Before recommending any injectable program, we review your metabolic health, blood glucose levels, kidney and liver function, cardiovascular history, and weight history. The right medication — and the right dose — depends on your specific biology, not a generic protocol.
Three injectable programs. One matched to your profile.
All programs are physician-supervised with regular monitoring. Your physician will recommend the right medication and dose based on your metabolic health, weight loss goals, and medical history.
Not sure which one? We'll guide you after reviewing your bloodwork.
The GLP-1 medication that changed the weight loss landscape. Semaglutide (Wegovy®/Ozempic®) is a once-weekly subcutaneous injection that reduces appetite, slows gastric emptying, and helps your body use stored fat more efficiently. Clinical trials show 10–15% average body weight reduction over 68 weeks.
The next evolution in injectable weight loss. Tirzepatide (Zepbound®/Mounjaro®) acts on both GLP-1 and GIP receptors — a dual mechanism that produces results approaching surgical weight loss outcomes in clinical trials. Average reduction of 22% of body weight over 72 weeks in SURMOUNT-1.
A physician-compounded blend of B vitamins, amino acids (methionine, inositol, choline), and metabolic cofactors delivered by injection to accelerate fat metabolism, support liver function, and boost energy during caloric restriction. Most effective as a complement to a primary weight loss program.
Semaglutide vs. Tirzepatide vs. Lipotropic — which is right for you?
This table is a guide. Your physician will confirm the best approach based on your labs, weight history, and goals.
| Feature | Semaglutide ⭐ | Tirzepatide | Lipotropic |
|---|---|---|---|
| Mechanism | GLP-1 agonist | GLP-1 + GIP dual agonist | Metabolic cofactors |
| Avg. weight loss | 10–20% body weight | Up to 22% body weight | Supportive (varies) |
| Injection frequency | Weekly | Weekly | Weekly |
| FDA approval | ✓ Wegovy® (weight) | ✓ Zepbound® (weight) | ✗ N/A (compounded) |
| Onset of effect | 4–8 weeks | 4–8 weeks | 2–4 weeks |
| Use standalone | ✓ Yes | ✓ Yes | ✗ Complement only |
| Best for | First-line, BMI 27+ | Aggressive goals, BMI 30+ | Any program add-on |
GLP-1 medications produce results that diet alone cannot.
The clinical evidence on GLP-1 receptor agonists is among the strongest ever published in obesity medicine. These aren't lifestyle aids — they are pharmaceutical interventions that change metabolic physiology. The question isn't whether they work. It's whether they're right for you — which is what your physician determines.
From your first visit to your first real results.
We review your weight history, metabolic health, previous attempts, and goals. You'll leave knowing exactly which program we recommend and why.
Comprehensive metabolic panel, kidney and liver function, fasting glucose, HbA1c, and cardiovascular screening. We need a complete picture before we prescribe.
Your physician prescribes the right medication at the right starting dose. We titrate slowly to minimize side effects. Your first injection can happen the same week.
Regular monitoring, dose adjustments, and support throughout your program. We track progress and make changes based on how your body responds — not a preset schedule.
Medicine that
gets you.
Over 15 years helping people in Las Vegas lose weight and keep it off — with FDA-approved medications and genuinely personalized medical oversight.
Physician-prescribed programs only
Every injectable program is prescribed and monitored by a licensed physician — not a wellness coach or supplement retailer.
FDA-approved medications
We use Semaglutide (Wegovy®) and Tirzepatide (Zepbound®) — both FDA-approved for chronic weight management with strong clinical evidence.
Individualized dosing protocols
We titrate every patient's dose based on their specific response, minimizing side effects and maximizing results.
Ongoing monitoring throughout
Monthly check-ins and lab reviews throughout your program. We adjust when your body adapts — before a plateau becomes a setback.
Real patients.
Real results.
Everything you
want to know.
Make this the last time
you start over.
A free consultation. A medical evaluation. A program built around your biology — not someone else's results. Most patients start their program within the same week.